Research ArticleOriginal Article
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao, Qian Zhao, Ding Yan, Ziying Lei, Yali Hao, Jinghong Chen, Qian Xue, Xiaofen Li, Qingtian Huang, Daolin Tang, Q. Ping Dou, Xin Chen and Jinbao Liu
Cancer Biology & Medicine July 2022, 19 (7) 1061-1077; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0598
Leyi Yao
1Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China
2Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China
3Institute of Digestive Disease of Guangzhou Medical University, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People’s Hospital, Qingyuan 511518, China
Qian Zhao
4School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China
Ding Yan
1Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China
2Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China
Ziying Lei
1Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China
Yali Hao
1Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China
2Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China
Jinghong Chen
2Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China
Qian Xue
1Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China
2Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China
Xiaofen Li
1Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China
2Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China
Qingtian Huang
1Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China
2Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China
Daolin Tang
5Department of Surgery, UT Southwestern Medical Center, Dallas, TX 75390, USA
Q. Ping Dou
6Barbara Ann Karmanos Cancer Institute and Departments of Oncology, Pharmacology & Pathology, School of Medicine, Wayne State University, Detroit, MI 48201, USA
Xin Chen
1Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China
2Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China
Jinbao Liu
1Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China
2Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China
3Institute of Digestive Disease of Guangzhou Medical University, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People’s Hospital, Qingyuan 511518, China
References
- 1.↵
- 2.↵
- Siegel R,
- Ma J,
- Zou Z,
- Jemal A.
- 3.↵
- 4.↵
- 5.↵
- Sun D,
- Li H,
- Cao M,
- He S,
- Lei L,
- Peng J, et al.
- 6.↵
- 7.↵
- Wilhelm SM,
- Carter C,
- Tang L,
- Wilkie D,
- McNabola A,
- Rong H, et al.
- 8.↵
- Llovet JM,
- Ricci S,
- Mazzaferro V,
- Hilgard P,
- Gane E,
- Blanc JF, et al.
- 9.↵
- Cheng AL,
- Kang YK,
- Chen Z,
- Tsao CJ,
- Qin S,
- Kim JS, et al.
- 10.↵
- Brose MS,
- Nutting CM,
- Jarzab B,
- Elisei R,
- Siena S,
- Bastholt L, et al.
- 11.
- 12.↵
- Zavaglia C,
- Airoldi A,
- Mancuso A,
- Vangeli M,
- Viganò R,
- Cordone G, et al.
- 13.↵
- Llovet JM,
- Peña CE,
- Lathia CD,
- Shan M,
- Meinhardt G,
- Bruix J.
- 14.↵
- Shao YY,
- Huang CC,
- Lin SD,
- Hsu CH,
- Cheng AL.
- 15.↵
- 16.↵
- 17.↵
- Fujiwara R,
- Haag M,
- Schaeffeler E,
- Nies AT,
- Zanger UM,
- Schwab M.
- 18.↵
- Johnson PJ,
- Berhane S,
- Kagebayashi C,
- Satomura S,
- Teng M,
- Reeves HL, et al.
- 19.↵
- Samawi HH,
- Sim HW,
- Chan KK,
- Alghamdi MA,
- Lee-Ying RM,
- Knox JJ, et al.
- 20.↵
- 21.↵
- Pinato DJ,
- Yen C,
- Bettinger D,
- Ramaswami R,
- Arizumi T,
- Ward C, et al.
- 22.↵
- 23.↵
- 24.↵
- Feoktistova M,
- Geserick P,
- Leverkus M.
- 25.↵
- Shi X,
- Chen X,
- Li X,
- Lan X,
- Zhao C,
- Liu S, et al.
- 26.↵
- 27.↵
- Livak KJ,
- Schmittgen TD.
- 28.↵
- 29.↵
- Yang HJ,
- Kong B,
- Shuai W,
- Zhang JJ,
- Huang H.
- 30.↵
- Garten A,
- Grohmann T,
- Kluckova K,
- Lavery GG,
- Kiess W,
- Penke M.
- 31.↵
- Senichkin VV,
- Streletskaia AY,
- Zhivotovsky B,
- Kopeina GS.
- 32.↵
- 33.↵
- Maurer U,
- Charvet C,
- Wagman AS,
- Dejardin E,
- Green DR.
- 34.↵
- Domina AM,
- Vrana JA,
- Gregory MA,
- Hann SR,
- Craig RW.
- 35.↵
- Ding Q,
- Xia W,
- Liu JC,
- Yang JY,
- Lee DF,
- Xia J, et al.
- 36.↵
- Liu L,
- Dong Z,
- Liang J,
- Cao C,
- Sun J,
- Ding Y, et al.
- 37.
- Hu D,
- Bi X,
- Fang W,
- Han A,
- Yang W.
- 38.
- Thornton TM,
- Pedraza-Alva G,
- Deng B,
- Wood CD,
- Aronshtam A,
- Clements JL, et al.
- 39.↵
- Jin F,
- Wu Z,
- Hu X,
- Zhang J,
- Gao Z,
- Han X, et al.
- 40.↵
- Hayashi T,
- Yamashita T,
- Terashima T,
- Suda T,
- Okada H,
- Asahina Y, et al.
- 41.
- 42.↵
- 43.↵
- 44.↵
- An C,
- Li X,
- Yu X,
- Cheng Z,
- Han Z,
- Liu F, et al.
- 45.↵
- Vítek L,
- Jirsa M,
- Brodanová M,
- Kalab M,
- Marecek Z,
- Danzig V, et al.
- 46.↵
- Huang H,
- Guo M,
- Liu N,
- Zhao C,
- Chen H,
- Wang X, et al.
- 47.↵
- Wang H,
- Guo M,
- Wei H,
- Chen Y.
- 48.↵
- Hsu C,
- Lin LI,
- Cheng YC,
- Feng ZR,
- Shao YY,
- Cheng AL, et al.
- 49.↵
- Liang YY,
- Deng XB,
- Zeng LS,
- Lin XT,
- Shao XF,
- Wang B, et al.
- 50.↵
- Tai WT,
- Shiau CW,
- Chen HL,
- Liu CY,
- Lin CS,
- Cheng AL, et al.
- 51.↵
- 52.↵
- 53.↵
- Hu X,
- Xia M,
- Wang J,
- Yu H,
- Chai J,
- Zhang Z, et al.
- 54.↵
- Wang Q,
- Zhou Y,
- Wang X,
- Evers BM.
- 55.↵
- Hansen TW,
- Mathiesen SB,
- Walaas SI.
- 56.↵
- Amit Y,
- Boneh A.
In this issue
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao, Qian Zhao, Ding Yan, Ziying Lei, Yali Hao, Jinghong Chen, Qian Xue, Xiaofen Li, Qingtian Huang, Daolin Tang, Q. Ping Dou, Xin Chen, Jinbao Liu
Cancer Biology & Medicine Jul 2022, 19 (7) 1061-1077; DOI: 10.20892/j.issn.2095-3941.2021.0598
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao, Qian Zhao, Ding Yan, Ziying Lei, Yali Hao, Jinghong Chen, Qian Xue, Xiaofen Li, Qingtian Huang, Daolin Tang, Q. Ping Dou, Xin Chen, Jinbao Liu
Cancer Biology & Medicine Jul 2022, 19 (7) 1061-1077; DOI: 10.20892/j.issn.2095-3941.2021.0598
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.